Challenge

Loyal set out to position itself as the pioneering leader in longevity science for dogs, with the future goal of also bringing lifespan extension drugs to humans.

SBS aimed to ensure that these breakthroughs resonate beyond the pet health space, making Loyal a topic of dinner table conversations and a prominent name in the broader conversation about scientific innovation and longevity.

Business Impact

Within just a few weeks of working together, SBS Comms positioned Loyal’s FDA RXE milestone as a game-changing breakthrough in veterinary medicine, securing major media placements in national news – including The Washington Post, People.com, The TODAY Show, The Late Show with Stephen Colbert, and The Drew Barrymore Show – demonstrating broad consumer interest and cultural relevance ahead of market availability.

Loyal’s founder, Celine Halioua, has been consistently positioned as a leader in longevity science in top tier business and technology outlets, culminating in a cover story in Forbes in August 2025. What started as a casual relationship building conversation with Forbes’ healthcare reporter in NYC, paired with a Forbes Next Billion Dollar Startups submission, resulted in an in-depth profile for Celine/Loyal and a video spotlight on the Forbes YouTube channel. With the support of SBS, Loyal’s vision and promise has resonated across audiences and geographies, from pet owners to vets to biotech investors around the world.